Afaxys Candid Conversations in Public Health

In our seventh episode of Afaxys Candid Conversations in Public Health, we discuss a truly “hot” topic—menopause. As a public benefit corporation devoted to serving safety net clinicians and their patients, Afaxys recognizes the disparities in menopause care for women seeking treatment at public health clinics, so we brought in world-renowned experts to talk about the ins and outs of menopause care, particularly during perimenopause. The esteemed Dr. Steven Goldstein and Dr. Lauren Streicher ...

In our sixth episode of Afaxys Candid Conversations in Public Health, we explore the world of contraception misinformation, disinformation and negative sentiment on social media. With our expert guests, Dr. Donna Adams-Pickett and Dr. Sarah Ann Anderson-Burnett, we define what contraception mis-/disinformation is (and what it is not). We walk through how clinicians can assess what sort of information their patients are seeing online, including how to query patients and tools such as Bedsider ...

In our fifth episode of Afaxys Candid Conversations in Public Health, we discuss the recently published “StepUp” randomized controlled trial of male partner treatment for the prevention of bacterial vaginosis (BV) recurrence in female partners with our expert guests, Dr. Craig Cohen and Dr. Ina Park. Building on our previous episode 4, part 2, we take a deep dive into the American College of Obstetricians and Gynecologists Clinical Practice Update: Concurrent Sexual Partner Therapy to Prevent...

In our third and fourth episodes of Afaxys Candid Conversations in Public Health, we talk with Dr. Olivia van Gerwen and Dr. Christina Muzny about recent updates in prevention strategies for HIV and bacterial vaginosis (BV). In Episode 3 (Part 1), Dr. Olivia “Libby” van Gerwen walks us through oral versus injectable medications as HIV prevention strategies, including the findings from the Purpose 1 and Purpose 2 trials of lenacapavir. We also discuss real-world nuances of HIV PrEP care ...

In our third and fourth episodes of Afaxys Candid Conversations in Public Health, we talk with Dr. Olivia van Gerwen and Dr. Christina Muzny about recent updates in prevention strategies for HIV and bacterial vaginosis (BV). In Episode 3 (Part 1), Dr. Olivia “Libby” van Gerwen walks us through oral versus injectable medications as HIV prevention strategies, including the findings from the Purpose 1 and Purpose 2 trials of lenacapavir. We also discuss real-world nuances of HIV PrEP care ...

In our second episode of Afaxys Candid Conversations in Public Health, we talk with Dr. Jen Karlin to explore how clinicians can stay up to date in sexual and reproductive healthcare while balancing evolving evidence, patient needs, and time constraints. The discussion covers practical continuing education strategies and trusted resources like Bedsider Providers+, the CDC’s Medical Eligibility Criteria (MEC) and Selected Practice Recommendations (SPR), and the Clinician Training Center for Se...

In our premiere episode of Afaxys Candid Conversations in Public Health, host Beth Attias sits down with leading experts Dr. Tammy Bennett and Dr. Kristin Metcalf-Wilson from the Clinical Training Center for Sexual and Reproductive Health (CTC-SRH), along with Dr. Kristen Feldman of Afaxys. Together, they explore the evolving landscape of STI clinical care in 2025—highlighting rising trends like the resurgence of syphilis, the growing role of point-of-care and at-home testing, and the importa...